Skip to main content
. 2014 Jun 29;232(1):305–314. doi: 10.1007/s00213-014-3666-3

Table 2.

Affinity of binding (pKi) of MOPr antagonists to MOPr expressed in HEK293 cells

pKi
GSK1521498 9.38 ± 0.10 (n = 7)
Naltrexone 9.15 ± 0.04 (n = 6)
6β-Naltrexol 9.12 ± 0.09 (n = 6)

Data are presented as mean ± SEM